Correlation Between AptaBio Therapeutics and Samsung Heavy

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both AptaBio Therapeutics and Samsung Heavy at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AptaBio Therapeutics and Samsung Heavy into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AptaBio Therapeutics and Samsung Heavy Industries, you can compare the effects of market volatilities on AptaBio Therapeutics and Samsung Heavy and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AptaBio Therapeutics with a short position of Samsung Heavy. Check out your portfolio center. Please also check ongoing floating volatility patterns of AptaBio Therapeutics and Samsung Heavy.

Diversification Opportunities for AptaBio Therapeutics and Samsung Heavy

-0.73
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between AptaBio and Samsung is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding AptaBio Therapeutics and Samsung Heavy Industries in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Samsung Heavy Industries and AptaBio Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AptaBio Therapeutics are associated (or correlated) with Samsung Heavy. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Samsung Heavy Industries has no effect on the direction of AptaBio Therapeutics i.e., AptaBio Therapeutics and Samsung Heavy go up and down completely randomly.

Pair Corralation between AptaBio Therapeutics and Samsung Heavy

Assuming the 90 days trading horizon AptaBio Therapeutics is expected to generate 2.28 times more return on investment than Samsung Heavy. However, AptaBio Therapeutics is 2.28 times more volatile than Samsung Heavy Industries. It trades about 0.04 of its potential returns per unit of risk. Samsung Heavy Industries is currently generating about 0.07 per unit of risk. If you would invest  606,000  in AptaBio Therapeutics on September 3, 2024 and sell it today you would earn a total of  46,000  from holding AptaBio Therapeutics or generate 7.59% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

AptaBio Therapeutics  vs.  Samsung Heavy Industries

 Performance 
       Timeline  
AptaBio Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days AptaBio Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Samsung Heavy Industries 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Samsung Heavy Industries are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Samsung Heavy sustained solid returns over the last few months and may actually be approaching a breakup point.

AptaBio Therapeutics and Samsung Heavy Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with AptaBio Therapeutics and Samsung Heavy

The main advantage of trading using opposite AptaBio Therapeutics and Samsung Heavy positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AptaBio Therapeutics position performs unexpectedly, Samsung Heavy can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Samsung Heavy will offset losses from the drop in Samsung Heavy's long position.
The idea behind AptaBio Therapeutics and Samsung Heavy Industries pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Complementary Tools

Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world